| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 01/31/2006 | US6991902 Nucleobase heterocyclic combinatorialization |
| 01/31/2006 | CA2346447C Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 01/25/2006 | EP1618204A2 Process for preparing dideoxyinosine using adenosine deaminase enzyme |
| 01/25/2006 | EP1495040A4 Method for synthesizing beta-l-fluoro-2',3'didehydcytidine (beta-l-fd4c) |
| 01/25/2006 | CN1726223A Process for purifying oligonucleotide synthons |
| 01/25/2006 | CN1724553A Synthesis method of 2-deoxy-2',2'-difluoro cytidine |
| 01/25/2006 | CN1723903A Matrix metalloproteinase and tumor necrosis factor inhibitors |
| 01/24/2006 | US6989376 Nervous system disorders; administering exogenous uridine compound |
| 01/24/2006 | US6989147 Tumor necrosis factor receptor protein for use in the treatment of arthritis |
| 01/19/2006 | WO2005108411A3 Substituted pixyl protecting groups for oligonucleotide synthesis |
| 01/19/2006 | US20060014972 Method of fluorination |
| 01/19/2006 | US20060014944 Processes for production of nucleosides |
| 01/19/2006 | US20060014943 Process for the synthesis of pyrazolopyrimidines |
| 01/19/2006 | CA2573532A1 Compositions and methods for detection of hepatitis a virus nucleic acid |
| 01/18/2006 | EP1616034A2 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 01/18/2006 | EP1404347B1 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 01/18/2006 | EP1097162B1 Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages |
| 01/18/2006 | CN1723216A Process for producing phosphoroamidite |
| 01/18/2006 | CN1723215A Anhydrous crystalline azido cytosine hemisulfate derivative |
| 01/18/2006 | CN1723214A Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 01/17/2006 | US6987180 Nucleoside phosphate having 5-aminouracil group for incorporation into DNA via treatment with oxidizing agent or alkaline solution which cleaves position of unnatural nucleotide base; polymerase chain reactions |
| 01/17/2006 | US6987177 Modified oligonucleotides, their preparation and their use |
| 01/17/2006 | US6987091 Sir2 products and activities |
| 01/12/2006 | US20060009636 Synthesis of protected 3'-amino nucleoside monomers |
| 01/12/2006 | US20060009635 Method for purifying 5' -protected 2' -deoxypurine nucleosides |
| 01/12/2006 | US20060009628 CONTAINING A 3-SUBSTITUTED PYRRAZOLO(,3,4-d) PYRIMIDINE |
| 01/12/2006 | US20060009417 Contacting (4S,2R,3R,5R)-2-(6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol with a protected (2-hydroxy) cyclopentylamine compound having a protecting group on the 2-hydroxy moiety;contacting=with thionyl chloride in the presence of a second base;contacting with base, removing protecting group |
| 01/12/2006 | US20060008461 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
| 01/12/2006 | US20060008459 Combination therapy of respiratory diseases using antibodies |
| 01/12/2006 | US20060008421 Pharmaceutical combination |
| 01/12/2006 | US20060005742 Pearl essence-analogous pearlescent pigments prepared by enzymatic reaction |
| 01/11/2006 | EP1341412B1 Indolocarbazole anticancer agents and methods of using them |
| 01/11/2006 | EP1276748B1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests |
| 01/11/2006 | EP1124839B1 Nucleosides with anti-hepatitis b virus activity |
| 01/11/2006 | EP1001035B1 Novel antibiotics rk-1061 and process for preparing the same |
| 01/11/2006 | EP0821692B1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 01/11/2006 | CN1720333A Gas jet process and apparatus for high-speed amplification of DNA |
| 01/11/2006 | CN1720332A Substrates for O6-alkylguanine-DNA alkyltransferase |
| 01/11/2006 | CN1720256A Method of fluorination |
| 01/10/2006 | US6984491 Detection of preferential nucleotide sequences in sample; obtain nucleotide sequence sample, incubate with oligonucleotide conjugated to nanoparticle, detect adjustment sequence activity, adjustment in activity indicates bound |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | CA2163520C L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 01/05/2006 | US20060003963 Oxidizing and fluorinating the anhydroglucose to obtain 2-deoxy-2,2-difluoro-D-ribofuranose as intermediate; can be used in large-scale production |
| 01/05/2006 | US20060003951 Anti-viral 7-deaza L-nucleosides |
| 01/05/2006 | US20060003349 Tm leveling compositions |
| 01/05/2006 | CA2567848A1 Methods and compositions for treating neuropathies |
| 01/04/2006 | EP1612213A1 Process for producing 2 -deoxy-2 -fluorouridine |
| 01/04/2006 | EP1610784A2 Forms of 5-azacytidine |
| 01/04/2006 | EP1265621B1 Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 01/04/2006 | EP0668931B1 Nucleic acid ligands and methods for producing the same |
| 01/04/2006 | CN1715918A Configurable dynamic three dimensional array |
| 01/03/2006 | CA2136622C Phosphotriester-type biologically active compounds |
| 01/03/2006 | CA2135853C Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides |
| 01/03/2006 | CA2135852C 5-methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4t) |
| 12/29/2005 | WO2005123755A2 Purine nucleotide derivatives |
| 12/29/2005 | WO2005094322A3 Effective treatment of tumors and cancer with triciribine and related compounds |
| 12/29/2005 | WO2005087788A3 Methods for preparation of nucleoside phosphonate esters |
| 12/29/2005 | US20050288500 synthesized by reacting a 2-chloro-6-substituted purine with a protected and activated 2-deoxy-2-fluoro-D-arabinofiranose; and reacting with a base such as ammonia to provide 2-chloro-9-(2-deoxy-2-fluoro- beta -D-arabinofuranosyl)-9H-purin-6-amine |
| 12/29/2005 | US20050288499 Modified guanosines having flavouring activity |
| 12/29/2005 | US20050288240 Conversion by human liver microsomes to MPO3H2; hepatitis, cancer, liver fibrosis, malaria, other viral and parasitic infections, and metabolic diseases where the liver is responsible for the overproduction of the biochemical end product, diabetes; enhanced oral drug delivery |
| 12/29/2005 | US20050288221 Glycopeptide antibiotics |
| 12/29/2005 | DE60202483T2 Verfahren zur herstellung von l-ribavirin A process for the preparation of L-Ribavirin |
| 12/29/2005 | CA2568907A1 8-carbyl substituted cyclic adenosine-3'-5'-monophosphorothiolate compounds as camp modulators |
| 12/28/2005 | EP1608688A2 Branched water-soluble polymers and their conjugates |
| 12/28/2005 | EP1608669A1 Silylated oligonucleotide compounds |
| 12/28/2005 | EP1608634A2 Methods for isolating crystalline form i of 5-azacytidine |
| 12/28/2005 | EP1497455A4 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 12/28/2005 | EP1427852A4 Single nucleotide amplification and detection by polymerase |
| 12/28/2005 | EP1421213A4 Labeled nucleoside polyphosphates |
| 12/28/2005 | EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides |
| 12/28/2005 | CN1714099A Antiviral nucleoside derivatives |
| 12/28/2005 | CN1714098A Crystalline and amorphous forms of beta-l-2'-deoxythymidine |
| 12/28/2005 | CN1714097A Organic compounds of 2'-o-trisubstituted siloxy methyl ribonucleoside derivatives and their preparation |
| 12/28/2005 | CN1714060A Method for deuteration or tritiation of heterocyclic ring |
| 12/28/2005 | CN1712409A Nucleoside fluoride compound, its production and use |
| 12/22/2005 | WO2005121361A2 Sequence-specific detection of methylation in biomolecules |
| 12/22/2005 | WO2005121162A1 3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF |
| 12/22/2005 | WO2005097814A3 Composition and method for inhibiting platelet aggregation |
| 12/22/2005 | WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof |
| 12/22/2005 | WO2005084367A3 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry |
| 12/22/2005 | US20050282769 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 12/22/2005 | US20050282768 Cardiovascular disease, a neurological disorder, an ischemic condition, a reperfusion injury, obesity, a wasting disease, or diabetes |
| 12/22/2005 | DE29825173U1 Fludarabine phosphate purification by precipitation from aqueous acetone as stable metal salt, useful as cytotoxic drug |
| 12/22/2005 | DE10120797B4 Verfahren zur Analyse von Nukleinsäureketten A process for the analysis of nucleic acid chains |
| 12/21/2005 | EP1606233A2 Nucleotide lipid ester derivatives |
| 12/21/2005 | EP1104436B1 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b virus |
| 12/21/2005 | CN1711278A Novel cytosine monophosphate medicine precursor |
| 12/20/2005 | US6977246 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| 12/20/2005 | US6977178 System and method for transgenic and targeted mutagenesis screening |
| 12/15/2005 | WO2005118608A2 2’-nitrobenzyl-modified ribonucleotides |
| 12/15/2005 | WO2005117910A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 12/15/2005 | WO2005079155A3 Photoreactive compound specifically binding to calcium binding proteins |
| 12/15/2005 | WO2004083258A3 Branched water-soluble polymers and their conjugates |
| 12/15/2005 | US20050277616 Thymine nucleosides with anti-hepatitis B virus activity |
| 12/15/2005 | US20050277614 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 12/15/2005 | CA2569491A1 2'-nitrobenzyl-modified ribonucleotides |
| 12/15/2005 | CA2567289A1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 12/14/2005 | EP1604995A1 Novel guanosine derivatives and use thereof |
| 12/14/2005 | EP1604671A1 Muscle-building agent and preventive or remedy for muscle weakening |
| 12/14/2005 | CN1706855A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |